Initial Registration Statement for Employee Benefit Plan Form S 8
U.S. Air Force Reserve Command
MH-139A Grey Wolf makes first ever guest appearance in exercise[...]
Regeneron Pharmaceuticals Inc.
Dupixent® (dupilumab) Approved in China as the First-ever Biologic[...]
09/27/2024 | Press release | Distributed by Public on 09/27/2024 06:02
Item 1.01 Entry into a Material Definitive Agreement.
See Item 2.03.
Please select the service you want to use:
Smartlinks | Non-Invasive Monitoring Systems Inc. | News | Health | Company News | Corporate Debt | Investment Funds | Lifestyle and Leisure | Leisure | Securities Issuers | Medical Technology Companies | OTC Markets
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact